Smith+Nephew is buying Integrity Orthopaedics to expand its shoulder portfolio.
The acquisition includes Integrity Orthopaedics’ Tendon Seam rotator cuff repair technology and is part of Smith+Nephew’s RISE strategy to accelerate growth, according to a Jan. 12 news release.
Integrity Orthopaedics’ Tendon Seam technology has the FDA’s 510(k) clearance and is indicated for reattachment of soft tissue to bone.
“Smith+Nephew now has an unrivalled portfolio for shoulder, including a powerful next‑generation rotator cuff repair platform to complement market-leading biological augmentation, the newest shoulder arthroplasty system, and proven solutions across shoulder instability,” Scott Schaffner, president of sports medicine at Smith+Nephew, said in the release. “We welcome the Integrity team, including those involved with our prior successful acquisition of Rotation Medical, and look forward to working together again to offer customers and their patients this exciting technology.”
The deal will include an initial cash payment of $225 million and additional performance-based payments of up to $225 million over the next five years. The transaction is expected to close by the end of January.
